Presentation is loading. Please wait.

Presentation is loading. Please wait.

Immunotherapeutics 18th Annual Research Retreat

Published byΣίβύλλα Γαλάνης Modified over 6 years ago

Similar presentations

Presentation on theme: "Immunotherapeutics 18th Annual Research Retreat"— Presentation transcript:

1 Immunotherapeutics 18th Annual Research Retreat
Sheraton Hotel Downtown Birmingham Monday, October 17, 2016 Immunotherapeutics KEYNOTE SPEAKERS Malcolm K. Brenner, M.D., Ph.D. Founding Director Center for Cell and Gene Therapy Baylor College of Medicine, Houston Methodist Hospital, Texas Children’s Hospital Madhav V. Dhodapkar, MBBS Chief, Section of Hematology Department of Internal Medicine Yale Cancer Center Leisha A. Emens, M.D., Ph.D. Associate Professor of Oncology School of Medicine Johns Hopkins University Kole T. Roybal, Ph.D. Jane Coffin Childs Fund Postdoctoral Fellow Howard Hughes Medical Institute Department of Cellular & Molecular Pharmacology University of California, San Francisco Registration and Abstract Submission: August 1 – September 16 Meeting Website: www3.ccc.uab.edu/index.php/research/research-retreat/

Download ppt "Immunotherapeutics 18th Annual Research Retreat"

Similar presentations

Follicular Lymphoma Transformed Lymphoma Diffuse Large B-Cell Lymphoma

Follicular Lymphoma Transformed Lymphoma Diffuse Large B-Cell Lymphoma
Hospital-Based Careers for Doctoral Scientists Bob Fader, Ph.D. D(ABMM) Section Chief, Microbiology/Virology Scott & White Healthcare Temple, TX

Hospital-Based Careers for Doctoral Scientists Bob Fader, Ph.D. D(ABMM) Section Chief, Microbiology/Virology Scott & White Healthcare Temple, TX
2014 TRAVEL AWARD RECIPIENTS

2014 TRAVEL AWARD RECIPIENTS
Steven Reed, Ph.D. Founder, Executive VP, Chief Scientific Officer, Corixa Corp. Founder, Director, Infectious Disease Research Institute Research Professor,

Steven Reed, Ph.D. Founder, Executive VP, Chief Scientific Officer, Corixa Corp. Founder, Director, Infectious Disease Research Institute Research Professor,
Module 2 Sealy Center on Aging What kinds of scholarly products can I produce?

Module 2 Sealy Center on Aging What kinds of scholarly products can I produce?
Welcome to the Fall 2010 TBPT Meeting Dr. Paul Klotman President and CEO Baylor College of Medicine November 3, 2010.

Welcome to the Fall 2010 TBPT Meeting Dr. Paul Klotman President and CEO Baylor College of Medicine November 3, 2010.
1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas 77056 713.963.5860 www.claytonbiotech.com Overview of Clayton Biotechnologies,

1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,
1 Howard Hughes Medical Institute Grants Program Goals are to strengthen science education and to cultivate the next generation of biomedical research.

1 Howard Hughes Medical Institute Grants Program Goals are to strengthen science education and to cultivate the next generation of biomedical research.
Bio-Tech Israel 2005 Conference & Exhibition May 24 – 26, 2005 David Intercontinental Hotel, Tel Aviv, Israel.

Bio-Tech Israel 2005 Conference & Exhibition May 24 – 26, 2005 David Intercontinental Hotel, Tel Aviv, Israel.
SAVE THE DATE 1 st International Workshop on HIV & Aging Deadline for applications to register: 7 August 2010 Deadline for abstract submission: 7 August.

SAVE THE DATE 1 st International Workshop on HIV & Aging Deadline for applications to register: 7 August 2010 Deadline for abstract submission: 7 August.
Norma M. Allewell The Postdoctoral Experience: What Works? What Doesn’t Work?

Norma M. Allewell The Postdoctoral Experience: What Works? What Doesn’t Work?
The Nobel Prize in Physiology or Medicine 1994 for their discovery of G-proteins and the role of these proteins in signal transduction in cells

The Nobel Prize in Physiology or Medicine 1994 "for their discovery of G-proteins and the role of these proteins in signal transduction in cells"
Improving the Process of Rare Disease Treatment Development Emil D. Kakkis, M.D., Ph.D. Chief Executive Officer and President, Ultragenyx Pharmaceutical,

Improving the Process of Rare Disease Treatment Development Emil D. Kakkis, M.D., Ph.D. Chief Executive Officer and President, Ultragenyx Pharmaceutical,
Dr. Neta Erez B.Sc. Faculty of Agriculture, Hebrew University

Dr. Neta Erez B.Sc. Faculty of Agriculture, Hebrew University
SARC Career Development Award Program Richard Gorlick, MD Lee Helman, MD.

SARC Career Development Award Program Richard Gorlick, MD Lee Helman, MD.
G. Scott Gazelle, MD, MPH, PhD Director, Partners Radiology Partners Radiology Research Retreat February 26, 2010.

G. Scott Gazelle, MD, MPH, PhD Director, Partners Radiology Partners Radiology Research Retreat February 26, 2010.
1 COMBIDEX ® (ferumoxtran-10). Introduction, Combidex, Indication Mark Roessel Vice President Regulatory Affairs, Advanced Magnetics, Inc.

1 COMBIDEX ® (ferumoxtran-10). Introduction, Combidex, Indication Mark Roessel Vice President Regulatory Affairs, Advanced Magnetics, Inc.
Guest Speakers Murray J. Côté, Ph.D. Associate Professor and Director, MHA Program August 21, 2013.

Guest Speakers Murray J. Côté, Ph.D. Associate Professor and Director, MHA Program August 21, 2013.
The Development of the Dystonia Concept The Hannover Lecture Stanley Fahn The Heiligendamm Round Table Organisation Dirk Dressler, MD, PhD.

The Development of the Dystonia Concept The Hannover Lecture Stanley Fahn The Heiligendamm Round Table Organisation Dirk Dressler, MD, PhD.
Sponsored Research Activities in Fiscal Year 2002 Research Administrators Forum February 13, 2003 Cynthia White Director, Research Office (From a 12/6/02.

Sponsored Research Activities in Fiscal Year 2002 Research Administrators Forum February 13, 2003 Cynthia White Director, Research Office (From a 12/6/02.

Similar presentations

Ads by Google